Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-24 @ 12:58 PM
NCT ID:
NCT01861561
Eligibility Criteria:
Inclusion Criteria:
* Child up to 15 years of age who fulfilled the 1997 updating the American College of Rheumatology revised criteria for the classification of SLE and his or her renal biopsy reveals lupus nephritis class III or IV regarding to International Society of Nephrology/Renal Pathology Society revision on the classification of the lupus nephritis.
Exclusion Criteria:
* patient who has prior renal insufficiency due to chronic kidney disease other than lupus nephritis
* patient who has the history of cyclophosphamide hypersensitivity
* patient who has prior cyclophosphamide or mycophenolate mofetil administration within 6 months
* patient who is pregnant
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
15 Years
Study:
NCT01861561
Study Brief:
Protocol Section:
NCT01861561